Cargando…
Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside
New drugs were recently developed to treat hyperglycemia in patients with type 2 diabetes mellitus (T2D). However, metformin remains the first-line anti-diabetic agent because of its cost-effectiveness. It has pleiotropic action that produces cardiovascular benefits, and it can be useful in diabetic...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146249/ https://www.ncbi.nlm.nih.gov/pubmed/33923115 http://dx.doi.org/10.3390/life11050389 |